MedPath

Proleukin

PROLEUKIN®

Approved
Approval ID

4e2b687e-47f2-4f3c-80ab-e3224befffca

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 23, 2019

Manufacturers
FDA

Prometheus Laboratories Inc.

DUNS: 967000860

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

aldesleukin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65483-116
Application NumberBLA103293
Product Classification
M
Marketing Category
C73585
G
Generic Name
aldesleukin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 31, 2018
FDA Product Classification

INGREDIENTS (6)

aldesleukinActive
Quantity: 1.1 mg in 1 mL
Code: M89N0Q7EQR
Classification: ACTIB
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORMInactive
Code: 3980JIH2SW
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORMInactive
Code: GR686LBA74
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Proleukin - FDA Drug Approval Details